The Anti-Cancer Role of Pterostilbene in Endometrial Cancer: A Phase II Prospective, Randomized, Window-of-Opportunity Clinical Trial with Megestrol Acetate.

Antioxidants (Basel) · 2025 · PMC11939256 · PMID 40227411

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The addition of pterostilbene suggested greater reduction in the cancer growth rate measure, Ki-67 index, in endometrial samples than compared with MA treatment alone, though did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.